Weekly Reports | Aug 13 2021
Our top ten news from 05 August 2021 to 12 August 2021 (ranked according to popularity).
1 – July In Review: ASX Rises While China Plummets
Thursday 05 August 2021
Gains in the mining sector spurred a 1.1% rise for the ASX200 in July, while Chinese stocks had the largest monthly decline in nearly a decade
2 – Rudi's View: August Bonanza, But What's Next?
Thursday 05 August 2021
In this week's Weekly Insights:-August Bonanza, But What's Next?-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor FNArenaAugust Bonanza, But What's Next?The upcoming August corporate reporting season should offer plenty of positives for Australian
3 – Defensive Stocks At The Right Price
Thursday 05 August 2021
The New Criterion's Tim Boreham looks at a range of stocks that can still be considered defensive in these times, when past defensives no longer are
4 – The Wrap: Vaccinations, Oz Banks, Consumption
Friday 06 August 2021
Weekly Broker Wrap: Vaccine rollouts critical to easing Sydney's restrictions; Oz banks limited upside; consumption benefits from excess savings
5 – Uranium Week: Kazatomprom Reports, SPUT Readies For Growth
Tuesday 10 August 2021
As the uranium spot price fell marginally last week, Kazatomprom released production and sales results, while the the Sprott Physical Uranium Trust achieved a key regulatory milestone in its plan to raise additional funds
6 – What To Expect This Reporting Season
Tuesday 10 August 2021
Despite heightened market uncertainty due to the recent round of lockdowns, brokers expect strong earnings growth to underpin market performance during the August reporting season
7 – Australian Broker Call *Extra* Edition – Aug 09, 2021
Monday 09 August 2021
Extra Edition of the Broker Call Report
8 – Weekly Ratings, Targets, Forecast Changes – 06-08-21
Monday 09 August 2021
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
9 – Will ResMed's Market Share Gains Last?
Monday 09 August 2021
Notwithstanding the difficulties in satisfying a surge in demand for sleep apnoea devices, ResMed should win market share. The main question is how much?
10 – Rudi's View: Early Days, But Plenty Of Signs
Thursday 12 August 2021
In this week's Weekly Insights:-Early Days, But Plenty Of Signs-Not To Be Forgotten: The Bond Market-Conviction Calls-FNArena Talks-All-Weather Model PortfolioBy Rudi Filapek-Vandyck, Editor FNArenaEarly Days, But Plenty Of SignsThe August reporting season in Australia is sti
